Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil

Universidade do Estado do Amazonas. Programa de Pós-Graduação em Medicina Tropica. Manaus, AM, Brasil / Fundação Alfredo da Matta. Manaus, AM, Brasil.
Fundação Alfredo da Matta. Manaus, AM, Brasil.
Fundação Alfredo da Matta. Manaus, AM, Brasil.
Fundação Alfredo da Matta. Manaus, AM, Brasil.
Fundação Alfredo da Matta. Manaus, AM, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ. Brasil.
Universidade do Estado do Amazonas. Programa de Pós-Graduação em Medicina Tropica. Manaus, AM, Brasil / Fundação Alfredo da Matta. Manaus, AM, Brasil / Universidade Nilton Lins. Manaus, AM, Brasil.

Abstract

Early detection of leprosy and multidrug therapy are crucial to achieve zero transmission and zero grade II incapacities goals of World Health Organization. Leprosy is difficult to diagnose because clinical forms vary and there are no gold standard methods to guide clinicians. The serological rapid tests aid the clinical diagnosis and are available for field use. They are easy to perform, do not require special equipment or refrigeration and are cheaper than the molecular tests.

Keywords in Portuguese

Hanseníase
Testes Sorológicos
Confiabilidade

Keywords

Leprosy
Accuracy
Serologic tests
PGL1
NDO-LID

Publisher

BMC

Citation

LETURIONDO, André Luiz et al. Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil. BMC Infectious Diseases, v. 19, n. 22, p. 1-6, 2019.

DOI

10.1186/s12879-018-3653-0

ISSN

1471-2334

Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/33780

Type

Copyright

Open access

Collections

Share

Statistics

Metadata

Author

Affilliation